S100B causes apoptosis in a myoblast cell line in a RAGE‐independent manner
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
S100B, a Ca 2+‐modulated protein with both intracellular and extracellular regulatory roles, is most abundant in astrocytes, is expressed in various amounts in several non‐nervous cells and is also found in normal serum. Astrocytes secrete S100B, and extracellular S100B exerts trophic and toxic effects on neurons depending on its concentration, in part by interacting with the receptor for advanced glycation end products (RAGE). The presence of S100B in normal serum and elevation of its serum concentration in several non‐nervous pathological conditions suggest that S100B‐expressing cells outside the brain might release the protein and S100B might affect non‐nervous cells. Recently we reported that at picomolar to nanomolar doses S100B inhibits rat L6 myoblast differentiation via inactivation of p38 kinase in a RAGE‐independent manner. We show here that at ≥5 nM in the absence of and at >100 nM in the presence of serum S100B causes myoblast apoptosis via stimulation of reactive oxygen species (ROS) production and inhibition of the pro‐survival kinase, extracellular signal‐regulated kinase (ERK)1/2, again in a RAGE‐independent manner. Together with our previous data, the present results suggest that S100B might participate in the regulation of muscle development and regeneration by two independent mechanism, i.e., by inhibiting crucial steps of the myogenic program at the physiological levels found in serum and by causing elevation of ROS production and myoblast apoptosis following accumulation in serum and/or muscle extracellular space. Our data also suggest that RAGE has no role in the transduction of S100B effects on myoblasts, implying that S100B can interact with more than one receptor to affect its target cells. J. Cell. Physiol. 199: 274–283, 2004© 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · cited 1×
“…et al., 2001) and shown to transduce inflammatory stimuli and effects of neurotrophic and neurotoxic factors and to have a role in tumor growth (Hori et al., 1995; Yan et al., 1996; Hofmann et al., 1999; Huttunen et al., 1999, 2000; Taguchi et al., 2000; Lue et al., 2001; Wendt et al., 2002).”
BackgroundDonato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580
Self-citationBlockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151 · cited 1×
“…et al., 2001) and shown to transduce inflammatory stimuli and effects of neurotrophic and neurotoxic factors and to have a role in tumor growth (Hori et al., 1995; Yan et al., 1996; Hofmann et al., 1999; Huttunen et al., 1999, 2000; Taguchi et al., 2000; Lue et al., 2001; Wendt et al., 2002).”
BackgroundIntracellular and extracellular roles of S100 proteins
Donato, R. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10296 · Cited by 974 · cited 1×
“…and chondrocytes, and in smaller amounts in several other cell types both in the nervous system (e.g., some neuronal populations and microglia cell lines) and outside the nervous system (e.g., renal cells, myoblasts, skeletal muscle cells, skin Langherans cells; for review see Donato, 2003).”
BackgroundSelf-citationLander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813 · cited 1×
“This observation also points to S100B binding to a receptor other than RAGE as RAGE engagement in other cell types results in MEK-ERK1/2 activation (Lander et al., 1997; Huttunen et al., 1999, 2000).”
Backgroundp38 Mitogen-activated Protein Kinase Pathway Promotes Skeletal Muscle Differentiation
Zetser, A., Gredinger, E., & Bengal, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5193 · Cited by 461
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Cited by
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
“Activation of ERK1/2 (p44/p42) MAP kinases has been shown in smooth muscle cells [11], tubular epithelial myofibroblasts [42], myoblasts [43], osteoblasts [44], and monocytic cells [45].”
BackgroundS100B's double life: Intracellular regulator and extracellular signal
Donato, R., Sorci, G., Riuzzi, F., Arcuri, C., Bianchi, R., Brozzi, F., Tubaro, C., & Giambanco, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.009 · Cited by 731
Self-citationBinding of S100 proteins to RAGE: An update
Leclerc, E., Fritz, G., Vetter, S. W., & Heizmann, C. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.016 · Cited by 489
Inflammation-associated S100 proteins: new mechanisms that regulate function
Goyette, J., & Geczy, C. L. (2011) · Amino Acids · doi:10.1007/s00726-010-0528-0 · Cited by 345
Proinflammatory S100 proteins in arthritis and autoimmune disease
Foell, D., & Roth, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20631 · Cited by 334
Ghavami, S., Eshragi, M., Ande, S. R., Chazin, W. J., Klonisch, T., Halayko, A. J., Mcneill, K. D., Hashemi, M., Kerkhoff, C., & Los, M. (2010) · Cell Research · doi:10.1038/cr.2009.129 · Cited by 267
S100B in neuropathologic states: The CRP of the brain?
Sen, J., & Belli, A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21211 · Cited by 258
Tsoporis, J. N., Izhar, S., Leong-Poi, H., Desjardins, J.-F., Huttunen, H. J., & Parker, T. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.195834 · Cited by 118
Cellular and molecular mechanisms of sarcopenia: The S100B perspective
Riuzzi, F., Sorci, G., Arcuri, C., Giambanco, I., Bellezza, I., Minelli, A., & Donato, R. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12363 · Cited by 114
“nase (GAPDH) activity by enhanced poly(ADP-ribosyl)ation of GAPDH with no apparent role for RAGE or FGFR.(116) Notably, muscles of S100B KO mice show reduced levels of poly(ADP-ribosyl)ated GAPDH,(118) but there is no information”
BackgroundInfluentialNeuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
Metadata
- Authors
- Sorci, G., Riuzzi, F., Agneletti, A. L., Marchetti, C., & Donato, R.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2003-10-28
- Volume
- 199
- Issue
- 2
- Pages
- 274-283
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2170894743
- Cited by
- 71
- References
- 9
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.